• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

223例乳腺癌中的均匀染色区:细胞遗传学与临床病理相关性

Homogeneously staining regions in 223 breast carcinomas: cytogenetic and clinicopathological correlations.

作者信息

Bernardino J, Gerbault-Seureau M, Zafrani B, Dericke Y, Boudou E, Magdelenat H, Dutrillaux B

机构信息

UMR 147 CNRS-Institut Curie, Section de Recherche, Paris, France.

出版信息

Br J Cancer. 1998 Nov;78(9):1214-8. doi: 10.1038/bjc.1998.657.

DOI:10.1038/bjc.1998.657
PMID:9820183
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2063008/
Abstract

A correlation analysis was performed on 223 breast carcinomas to assess the relationships between gene amplification, karyotypic and clinicopathological features. Homogeneously staining region (HSR) is the most frequent form of amplification found in breast cancer. HSR-containing tumours accounted for 60% of the cases. Although up to 40% of tumours with slightly altered karyotype contained HSRs, an excess of HSRs was found within the tumours whose karyotype showed the highest rates of rearranged chromosomes. HSRs were also found to be particularly frequent in small tumours of high histological grade and with a low expression of progesterone receptors. An excess of HSRs seems to be observed in younger patients, however, significant correlation could be demonstrated only for patients below 55 years and below 60 years, compared with older ones. With a 120-month follow-up for 152 patients, a significant association between the presence of HSRs and a shortened overall survival was observed. Altogether, the presence of HSRs appears to be a good indicator of poor prognosis. Further studies are needed to determine whether amplification of specific genes or cell ability to amplify is the most important parameter for tumour progression.

摘要

对223例乳腺癌进行了相关性分析,以评估基因扩增、核型与临床病理特征之间的关系。均匀染色区(HSR)是乳腺癌中最常见的扩增形式。含HSR的肿瘤占病例的60%。虽然高达40%核型略有改变的肿瘤含有HSR,但在核型显示染色体重排率最高的肿瘤中发现了过量的HSR。HSR在高组织学分级且孕激素受体低表达的小肿瘤中也特别常见。在年轻患者中似乎观察到HSR过量,然而,与老年患者相比,仅在55岁以下和60岁以下的患者中可证明存在显著相关性。对152例患者进行120个月的随访,观察到HSR的存在与总生存期缩短之间存在显著关联。总之,HSR的存在似乎是预后不良的一个良好指标。需要进一步研究以确定特定基因的扩增或细胞扩增能力是否是肿瘤进展的最重要参数。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c51/2063008/2ee9ffaa1a09/brjcancer00013-0098-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c51/2063008/2ee9ffaa1a09/brjcancer00013-0098-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c51/2063008/2ee9ffaa1a09/brjcancer00013-0098-a.jpg

相似文献

1
Homogeneously staining regions in 223 breast carcinomas: cytogenetic and clinicopathological correlations.223例乳腺癌中的均匀染色区:细胞遗传学与临床病理相关性
Br J Cancer. 1998 Nov;78(9):1214-8. doi: 10.1038/bjc.1998.657.
2
Cytogenetic study of breast cancer: clinicopathologic significance of homogeneously staining regions in 84 patients.
Hum Pathol. 1992 May;23(5):542-7. doi: 10.1016/0046-8177(92)90131-l.
3
Recurrent homogeneously staining regions in 8p1 in breast cancer and lack of amplification of POLB, LHRH, and PLAT genes.
Cancer Genet Cytogenet. 1991 Mar;52(1):27-35. doi: 10.1016/0165-4608(91)90050-5.
4
Characterization of recurrent homogeneously staining regions in 72 breast carcinomas.72例乳腺癌中复发性均匀染色区域的特征分析
Genes Chromosomes Cancer. 1998 Oct;23(2):100-8. doi: 10.1002/(sici)1098-2264(199810)23:2<100::aid-gcc2>3.0.co;2-6.
5
[Amplification of portions of the genome in mammalian somatic cells resistant to colchicine. II. Marker chromosomes with long homogeneously staining regions in colchicine-resistant cells of the Djungarian hamster].[秋水仙素抗性哺乳动物体细胞中基因组部分区域的扩增。II. 黑线仓鼠秋水仙素抗性细胞中带有长的均匀染色区的标记染色体]
Genetika. 1982 Sep;18(9):1513-23.
6
Does MYCN amplification manifested as homogeneously staining regions at diagnosis predict a worse outcome in children with neuroblastoma? A Children's Oncology Group study.诊断时表现为均匀染色区的MYCN扩增是否预示着神经母细胞瘤患儿的预后更差?一项儿童肿瘤学组的研究。
Clin Cancer Res. 2006 Oct 1;12(19):5693-7. doi: 10.1158/1078-0432.CCR-06-1500.
7
Recurrent HSR in the centromeric region of chromosome 8 in breast cancer.
Ann Genet. 1987;30(3):146-51.
8
Differential expression of progesterone receptor, FOXA1, GATA3, and p53 between pre- and postmenopausal women with estrogen receptor-positive breast cancer.雌激素受体阳性乳腺癌绝经前后女性之间孕激素受体、FOXA1、GATA3和p53的差异表达
Breast Cancer Res Treat. 2014 Apr;144(2):249-61. doi: 10.1007/s10549-014-2867-0. Epub 2014 Feb 19.
9
Flow cytometric DNA hypertetraploidy is associated with unfavourable prognostic features in breast cancer.流式细胞术检测的DNA超四倍体与乳腺癌预后不良特征相关。
J Clin Pathol. 1997 Jul;50(7):591-5. doi: 10.1136/jcp.50.7.591.
10
EGFR expression and activation are common in HER2 positive and triple-negative breast tumours.表皮生长因子受体(EGFR)的表达和激活在 HER2 阳性和三阴性乳腺癌中很常见。
Histol Histopathol. 2010 Sep;25(9):1171-9. doi: 10.14670/HH-25.1171.

引用本文的文献

1
An array CGH based genomic instability index (G2I) is predictive of clinical outcome in breast cancer and reveals a subset of tumors without lymph node involvement but with poor prognosis.基于 array CGH 的基因组不稳定性指数 (G2I) 可预测乳腺癌的临床结局,并揭示了一组无淋巴结受累但预后不良的肿瘤亚群。
BMC Med Genomics. 2012 Nov 27;5:54. doi: 10.1186/1755-8794-5-54.

本文引用的文献

1
Genetic alterations in breast cancer.乳腺癌中的基因改变。
Genes Chromosomes Cancer. 1995 Dec;14(4):227-51. doi: 10.1002/gcc.2870140402.
2
Correlation between karyotypic pattern and clincopathologic features in 125 breast cancer cases.
Int J Cancer. 1996 Apr 10;66(2):191-6. doi: 10.1002/(SICI)1097-0215(19960410)66:2<191::AID-IJC9>3.0.CO;2-Y.
3
Identification of amplified DNA sequences in breast cancer and their organization within homogeneously staining regions.乳腺癌中扩增DNA序列的鉴定及其在均匀染色区的组织形式
Genes Chromosomes Cancer. 1995 Nov;14(3):155-63. doi: 10.1002/gcc.2870140302.
4
Gene amplification and tumor progression.基因扩增与肿瘤进展。
Biochim Biophys Acta. 1993 May 25;1155(1):25-41. doi: 10.1016/0304-419x(93)90020-d.
5
Cytogenetics and clinical correlations in breast cancer.乳腺癌的细胞遗传学与临床关联
Adv Exp Med Biol. 1993;330:107-18. doi: 10.1007/978-1-4615-2926-2_9.
6
Amplification and overexpression of the erbB-2 gene in human tumors: its involvement in tumor development, significance as a prognostic factor, and potential as a target for cancer therapy.erbB-2基因在人类肿瘤中的扩增与过表达:其在肿瘤发生发展中的作用、作为预后因素的意义以及作为癌症治疗靶点的潜力。
Semin Cancer Biol. 1993 Feb;4(1):19-26.
7
Oncogene amplification in human gliomas: a molecular cytogenetic analysis.人类胶质瘤中的癌基因扩增:分子细胞遗传学分析
Oncogene. 1994 Sep;9(9):2717-22.
8
Overexpression of p53 and HER-2/neu proteins as prognostic markers in early stage breast cancer.p53和HER-2/neu蛋白的过表达作为早期乳腺癌的预后标志物
Ann Surg. 1994 Apr;219(4):332-41. doi: 10.1097/00000658-199404000-00002.
9
Identification of cryptic sites of DNA sequence amplification in human breast cancer by chromosome microdissection.通过染色体显微切割鉴定人类乳腺癌中DNA序列扩增的隐匿位点。
Nat Genet. 1994 Oct;8(2):155-61. doi: 10.1038/ng1094-155.
10
The biology of erbB-2/neu/HER-2 and its role in cancer.erbB-2/neu/HER-2的生物学特性及其在癌症中的作用。
Biochim Biophys Acta. 1994 Dec 30;1198(2-3):165-84. doi: 10.1016/0304-419x(94)90012-4.